Chemoprevention with green propolis green propolis extracted in L-lysine versus carcinogenesis promotion with L-lysine in N-Butyl-N-[4-hydroxybutyl] nitrosamine (BBN) induced rat bladder cancer.

PURPOSE To determine the effects of green propolis extracted in L-lysine (WSDP) and of L- lysine for 40 weeks on induced rat bladder carcinogenesis. METHODS The animals (groups I, II, III, IV, V and VI) received BBN during 14 weeks. Group I was treated with propolis 30 days prior received BBN, and then these animals were treated daily with propolis; Groups II and III was treated with subcutaneous and oral propolis (respectively) concurrently with BBN. The animals of Group IV were treated L-lysine; Group V received water subcutaneous; and Group VI received only to BBN. Among the animals not submitted to carcinogenesis induction, Group VII received propolis, Group VIII received L-lysine and Group IX received water. RESULTS The carcinoma incidence in Group I was lower than that of control (Group VI). The carcinoma multiplicity in Group IV was greater than in Group VI. All animals treated with L-lysine developed carcinomas, and they were also more invasive in Group IV than in controls. On the other hand, Group VIII showed no bladder lesions. CONCLUSION The WSDP is chemopreventive against rat bladder carcinogenesis, if administered 30 days prior to BBN , and that L-lysine causes promotion of bladder carcinogenesis.

[1]  I. Basic,et al.  Propolis and its flavonoid compounds cause cytotoxicity on human urinary bladder transitional cell carcinoma in primary culture , 2009 .

[2]  J. M. Sforcin,et al.  In vitro Cytotoxic Effect of Brazilian Green Propolis on Human Laryngeal Epidermoid Carcinoma (HEp-2) Cells , 2007, Evidence-based complementary and alternative medicine : eCAM.

[3]  E. L. Maistro,et al.  First in vivo evaluation of the mutagenic effect of Brazilian green propolis by comet assay and micronucleus test. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[4]  G. Vargas,et al.  IMUNOMODULAÇÃO PELA PRÓPOLIS , 2008 .

[5]  H. Esumi,et al.  Constituents of Brazilian red propolis and their preferential cytotoxic activity against human pancreatic PANC-1 cancer cell line in nutrient-deprived condition. , 2008, Bioorganic & medicinal chemistry.

[6]  S. M. Alencar,et al.  Própolis do sudeste e nordeste do Brasil: influência da sazonalidade na atividade antibacteriana e composição fenólica , 2007 .

[7]  E. Messing,et al.  Chemoprevention of bladder cancer , 2006, World Journal of Urology.

[8]  P. Oliveira,et al.  Experimental bladder carcinogenesis-rodent models. , 2006, Experimental oncology.

[9]  I. Basic,et al.  Water-soluble derivative of propolis and its polyphenolic compounds enhance tumoricidal activity of macrophages. , 2005, Journal of ethnopharmacology.

[10]  L. Šver,et al.  Effects of local administration of propolis and its polyphenolic compounds on tumor formation and growth. , 2005, Biological & pharmaceutical bulletin.

[11]  I. Kosalec,et al.  Synergistic antitumor effect of polyphenolic components of water soluble derivative of propolis against Ehrlich ascites tumour. , 2005, Biological & pharmaceutical bulletin.

[12]  L. Šver,et al.  Immunomodulatory and antimetastatic action of propolis and related polyphenolic compounds. , 2004, Journal of ethnopharmacology.

[13]  L. C. Simões,et al.  Effect of Brazilian green propolis on the production of reactive oxygen species by stimulated neutrophils. , 2004, Journal of ethnopharmacology.

[14]  H. Yamada,et al.  Inhibitory effects of propolis granular A P C on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. , 2003, Cancer letters.

[15]  I. Hayashi,et al.  Antitumor and anticytopenic effects of aqueous extracts of propolis in combination with chemotherapeutic agents. , 2002, Cancer biotherapy & radiopharmaceuticals.

[16]  M. Micallef,et al.  Pulmonary carcinogenesis induced by ferric nitrilotriacetate in mice and protection from it by Brazilian propolis and artepillin C , 2001, Virchows Archiv.

[17]  S. Fukushima,et al.  Prevention of Urinary Bladder Cancer: The Interface Between Experimental and Human Studies. , 2000, Asian Pacific journal of cancer prevention : APJCP.

[18]  H. Nagasawa,et al.  Effects of a new clerodane diterpenoid isolated from propolis on chemically induced skin tumors in mice. , 1996, Anticancer research.

[19]  M. Kurimoto,et al.  Isolation and identification of antimicrobial compounds in Brazilian propolis , 1994 .

[20]  International classification of rodent tumours. Part I--The rat. 6. Endocrine system. , 1994, IARC scientific publications.

[21]  S. Fukushima.  Modification of tumor development in the urinary bladder. , 1991, Progress in experimental tumor research.

[22]  N Ito,et al.  Promotion of urinary bladder carcinogenesis in experimental animals. , 1989, Experimental pathology.

[23]  T. Kakizoe,et al.  L-isoleucine and L-leucine: tumor promoters of bladder cancer in rats. , 1986, Science.

[24]  T. Kakizoe,et al.  Detection of amino acids as possible promoters of bladder cancer in rats by measuring their enhancement of agglutination of bladder cells by concanavalin A. , 1982, Gan.

[25]  Eric B. Sansone,et al.  Laboratory decontamination and destruction of carcinogens in laboratory wastes: some N-nitrosamines. , 1982, IARC scientific publications.

[26]  S. Brown.  Handling Chemical Carcinogens in the Laboratory—Problems of Safety , 1981, IARC scientific publications.

[27]  S. Cohen,et al.  Promoting effect of saccharin and DL-tryptophan in urinary bladder carcinogenesis. , 1979, Cancer research.

[28]  C. Frankson.  Tumor of the urinary bladder , 1950 .